Pharmaceutical companies have been racing to develop effective pain treatment alternatives that don't have the addictive properties of opioids
Howard Fine is a Reporter at the Los Angeles Business Journal. With over 23 years of experience, he specializes in healthcare, biomedicine, energy, engineering, and construction, often exploring the intersection of these fields with urban development and design. His work has earned him multiple accolades, including Best Body of Work from the Alliance of Area Business Publishers and Distinguished Journalist of the Year from the Society of Professional Journalists, and he is featured in the Los Angeles Business Journal.